Thomas Zichner

Years Active: 2019-2019
Publications (10 Years): 2

Boehringer Ingelheim RCV GmbH & Co KG

European Molecular Biology Laboratory (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boehringer Ingelheim RCV GmbH & Co KG

Austria

Distinguished Scientist :: Cancer Research

Boehringer Ingelheim RCV GmbH & Co KG

Austria

Postdoctoral researcher :: Cancer research

European Molecular Biology Laboratory

Germany

Postdoctoral Research Fellow

European Molecular Biology Laboratory

Germany

PhD Student :: Genome Biology

Royal Institute of Technology, KTH

Sweden

Internship :: Biotechnology

Education History

European Molecular Biology Laboratory

Germany

PHD :: Genome Biology

Hogskolan i Skovde

Sweden

MSC

Publications

Katharina Ehrenhöfer-Wölfer, Teresa Puchner, Cornelia Schwarz, Janine Rippka, Silvia Blaha-Ostermann, Ursula Strobl, Alexandra Hörmann, Gerd Bader, Stefan Kornigg, Stephan Zahn, Wolfgang Sommergruber, Norbert Schweifer, Thomas Zichner, Andreas Schlattl, Ralph A Neumüller, Junwei Shi, Christopher R Vakoc, Manfred Kögl, Mark Petronczki, Norbert Kraut, Mark A Pearson, Simon Wöhrle
SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines. Scientific reports 9 (1) (2019)
Henning Zelba, Jens Bedke, Jörg Hennenlotter, Sven Mostböck, Markus Zettl, Thomas Zichner, Anoop Chandran, Arnulf Stenzl, Hans-Georg Rammensee, Cécile Gouttefangeas
PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma. Cancer immunology research 7 (11) (2019)

Thomas Zichner.css-eqlu8i{font-size:small;padding-left:4px;}